RIGL logo

Rigel Pharmaceuticals, Inc. (RIGL)

Profile

Full Name

Rigel Pharmaceuticals, Inc.

Ticker

NASDAQ: RIGL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 29, 2000

Indexes

Not included

Website

https://www.rigel.com

Employees

162

Key Details

Price

$37.96(+0.37%)

Market cap

$680.90M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$179.28M(+53.38% YoY)

Annual EPS

$0.99(+170.71% YoY)

PE ratio

7.02

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $37.96
    RIGL price is $37.96

    30-Day Relative Volume

    0.44
    RIGL 30-day relative volume is 0.44

    Price Performance

    Price Most recent change

    +0.37%
    RIGL price was up +0.37% on Sep 12, 2025

    Price YTD change

    +125.68%
    RIGL price is up +125.68% since January 1st

    Price 1-year change

    +193.13%
    RIGL price is up +193.13% year-on-year

    Price 3-year change

    +165.45%
    RIGL price is up +165.45% over the past 3 years

    Price Range

    Price All-time high

    $1147.50
    RIGL price is currently -96.69% below its historical high of $1147.50

    Price 3-year low

    $6.70
    RIGL price is currently +466.57% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $680.90M
    RIGL market capitalization is $680.90 million

    Market cap 3-year change

    +175.49%
    RIGL market capitalization is up +175.49% over the past 3 years

    Market cap All-time high

    $939.37M
    RIGL market capitalization is currently -27.52% below its historical high of $939.37 million

    Market cap sector rank

    67.62%
    RIGL market capitalization is higher than 67.62% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.95%
    RIGL shares outstanding is up +1.95% year-on-year

    Shares Outstanding 3-Year Change

    +3.78%
    RIGL shares outstanding is up +3.78% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.12
    RIGL beta is 1.12

    200-day SMA

    $22.38
    RIGL price is currently +69.65% above its 200-day simple moving average

    50-day SMA

    $29.75
    RIGL price is currently +27.58% above its 50-day simple moving average

    RSI

    56.17
    RIGL 14-day relative strength index is 56.17

    Volume

    0.44
    RIGL 30-day relative volume is 0.44

    ATR

    $2.13
    RIGL average true range is $2.13

    10-day Historical Volatility

    71.96%
    RIGL 10-day historical volatility is 71.96%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $179.28M
    RIGL annual revenue is $179.28 million

    Revenue Analysts estimate

    $281.09M
    RIGL annual revenue is currently -36.22% lower than the consensus analysts' forecast

    Revenue 1-year change

    +53.38%
    RIGL annual revenue is up +53.38% year-on-year

    Revenue Sector rank

    72.83%
    RIGL annual revenue is higher than 72.83% of companies in Healthcare sector

    EPS

    EPS

    $0.99
    RIGL annual earnings per share is $0.99

    EPS Analysts estimate

    $4.91
    RIGL annual earnings per share is currently -79.85% lower than the consensus analysts' forecast

    EPS 1-year change

    +170.71%
    RIGL annual earnings per share is up +170.71% year-on-year

    EPS Sector rank

    89.06%
    RIGL annual earnings per share is higher than 89.06% of companies in Healthcare sector

    Profit

    Gross profit

    $160.63M
    RIGL annual gross profit is $160.63 million

    Gross margin

    89.60%
    RIGL annual gross profit margin is 89.60%

    Operating profit

    $24.19M
    RIGL annual operating income is $24.19 million

    Operating margin

    13.49%
    RIGL annual operating profit margin is 13.49%

    Net income

    $17.48M
    RIGL annual net profit is $17.48 million

    Net margin

    9.75%
    RIGL annual net profit margin is 9.75%

    Expenses

    Total expenses

    $161.79M
    RIGL annual total expenses is $161.79 million

    Operating expenses

    $136.44M
    RIGL annual total operating expenses is $136.44 million

    Cost of goods sold

    $18.65M
    RIGL annual cost of goods sold is $18.65 million

    Selling, general & administrative expenses

    $0.00
    RIGL annual SGA is $0.00

    Depreciation and amortization

    $2.23M
    RIGL annual depreciation & amortization is $2.23 million

    Interest expense

    $0.00
    RIGL annual interest expense is $0.00

    Income tax

    $881.00K
    RIGL annual income tax is $881.00 thousand

    EBIT & EBITDA

    EBIT

    $24.19M
    RIGL annual earnings before interest & taxes is $24.19 million

    EBITDA

    $26.42M
    RIGL annual EBITDA is $26.42 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $493.21M
    RIGL annual total assets is $493.21 million

    Non current assets

    $28.87M
    RIGL annual long term assets is $28.87 million

    Current assets

    $135.10M
    RIGL annual total current assets is $135.10 million

    Cash and cash equivalents

    $77.32M
    RIGL annual cash & cash equivalents is $77.32 million

    Accounts receivable

    $41.62M
    RIGL annual accounts receivable is $41.62 million

    Inventory

    $9.80M
    RIGL annual inventory is $9.80 million

    Liabilities

    Total liabilities

    $489.92M
    RIGL annual total liabilities is $489.92 million

    Long term liabilities

    $374.21M
    RIGL annual total long term liabilities is $374.21 million

    Current liabilities

    $63.30M
    RIGL annual total current liabilities is $63.30 million

    Accounts payable

    $3.34M
    RIGL annual accounts payable is $3.34 million

    Debt

    Total debt

    $59.97M
    RIGL annual total debt is $59.97 million

    Total debt 1-year change

    -1.01%
    RIGL annual total debt is down -1.01% year-on-year

    Long term debt

    $52.41M
    RIGL annual long term debt is $52.41 million

    Short term debt

    $7.56M
    RIGL annual short term debt is $7.56 million

    Equity & Capital

    Shareholders equity

    $3.29M
    RIGL annual stockholders equity is $3.29 million

    Book value

    $3.29M
    RIGL annual book value is $3.29 million

    Retained earnings

    -$1.39B
    RIGL annual retained earnings is -$1.39 billion

    Working capital

    $71.80M
    RIGL annual working capital is $71.80 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $31.47M
    RIGL annual cash flow from operations is $31.47 million

    Cash from operations 1-year change

    +647.99%
    RIGL annual cash flow from operations is up +647.99% year-on-year

    Cash from investing

    $4.13M
    RIGL annual cash flow from investing activities is $4.13 million

    Cash from investing 1-year change

    +196.11%
    RIGL annual cash flow from investing activities is up +196.11% year-on-year

    Cash from financing

    -$11.64M
    RIGL annual cash flow from financing activities is -$11.64 million

    Cash from financing 1-year change

    -163.38%
    RIGL annual cash flow from financing activities is down -163.38% year-on-year

    CAPEX

    CAPEX

    $396.00K
    RIGL annual capital expenditures is $396.00 thousand

    CAPEX 1-year change

    -97.36%
    RIGL annual capital expenditures is down -97.36% year-on-year

    Free Cash Flow

    Free cash flow

    $31.07M
    RIGL annual free cash flow is $31.07 million

    Free cash flow 1-year change

    +249.81%
    RIGL annual free cash flow is up +249.81% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    89.60%
    RIGL annual gross profit margin is 89.60%

    Operating margin

    13.49%
    RIGL annual operating profit margin is 13.49%

    Net margin

    9.75%
    RIGL annual net profit margin is 9.75%

    ROA & ROE

    ROA

    5.73%
    RIGL annual return on assets is 5.73%

    ROE

    531.78%
    RIGL annual return on equity is 531.78%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    7.02
    RIGL price to earnings ratio is 7.02

    PE ratio Sector rank

    11.79%
    RIGL price to earnings ratio is higher than 11.79% of companies in Healthcare sector

    PB Ratio

    PB ratio

    8.31
    RIGL price to book ratio is 8.31

    PB ratio Sector rank

    86.68%
    RIGL price to book ratio is higher than 86.68% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.54
    RIGL price to sales ratio is 2.54

    PS ratio Sector rank

    41.14%
    RIGL price to sales ratio is higher than 41.14% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $633.56M
    RIGL enterprise value is $633.56 million

    Enterprise value Sector rank

    68.36%
    RIGL enterprise value is higher than 68.36% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    5.80
    RIGL EV/EBITDA is 5.80

    EV/EBITDA Sector rank

    77.62%
    RIGL EV/EBITDA is higher than 77.62% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.13
    RIGL annual current ratio is 2.13

    Quick ratio

    1.98
    RIGL annual quick ratio is 1.98

    Leverage

    Debt to equity

    18.24
    RIGL annual debt to equity ratio is 18.24

    Interest coverage ratio

    -
    RIGL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    RIGL piotroski f-score is 6

    Altman Z-Score

    -2.41
    RIGL altman z-score is -2.41

    Analyst ratings

    Recent major analysts updates

    Aug 6, 25 Cantor Fitzgerald
    Neutral
    May 7, 25 Cantor Fitzgerald
    Neutral
    Mar 6, 25 Citigroup
    Buy
    Mar 5, 25 HC Wainwright & Co.
    Buy
    Mar 5, 25 B. Riley Securities
    Neutral
    Jan 23, 25 HC Wainwright & Co.
    Buy
    Jan 22, 25 HC Wainwright & Co.
    Buy
    Jan 14, 25 HC Wainwright & Co.
    Buy
    Dec 10, 24 HC Wainwright & Co.
    Buy
    Dec 10, 24 Cantor Fitzgerald
    Neutral

    Institutional Ownership

    Screeners with RIGL included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    • What is the ticker symbol for Rigel Pharmaceuticals, Inc.?
    • Does Rigel Pharmaceuticals, Inc. pay dividends?
    • What sector is Rigel Pharmaceuticals, Inc. in?
    • What industry is Rigel Pharmaceuticals, Inc. in?
    • What country is Rigel Pharmaceuticals, Inc. based in?
    • When did Rigel Pharmaceuticals, Inc. go public?
    • Is Rigel Pharmaceuticals, Inc. in the S&P 500?
    • Is Rigel Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Rigel Pharmaceuticals, Inc. in the Dow Jones?
    • When was Rigel Pharmaceuticals, Inc.'s last earnings report?
    • When does Rigel Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Rigel Pharmaceuticals, Inc.?

    The ticker symbol for Rigel Pharmaceuticals, Inc. is NASDAQ:RIGL

    Does Rigel Pharmaceuticals, Inc. pay dividends?

    No, Rigel Pharmaceuticals, Inc. does not pay dividends

    What sector is Rigel Pharmaceuticals, Inc. in?

    Rigel Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Rigel Pharmaceuticals, Inc. in?

    Rigel Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Rigel Pharmaceuticals, Inc. based in?

    Rigel Pharmaceuticals, Inc. is headquartered in United States

    When did Rigel Pharmaceuticals, Inc. go public?

    Rigel Pharmaceuticals, Inc.'s initial public offering (IPO) was on November 29, 2000

    Is Rigel Pharmaceuticals, Inc. in the S&P 500?

    No, Rigel Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Rigel Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Rigel Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Rigel Pharmaceuticals, Inc. in the Dow Jones?

    No, Rigel Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Rigel Pharmaceuticals, Inc.'s last earnings report?

    Rigel Pharmaceuticals, Inc.'s most recent earnings report was on August 5, 2025

    When does Rigel Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Rigel Pharmaceuticals, Inc. is November 6, 2025
    On this page